A Note of Thanks
Peer review is the lifeblood of scientific publishing. To maintain the highest standards for the content of manuscripts published in Insulin, we seek independent reviewers from the faculties of medical schools and schools of pharmacy worldwide. Not only are our reviewers asked to provide in-depth reviews, but they are asked to do so within a short period of time.
Physicians’ Corner—In Search of the Holy Grail? The Quest to Reduce Macrovascular Disease in Type 2 Diabetes Mellitus
Charles F. Shaefer, Jr.
Intensive diabetes control based on low glycosylated hemoglobin levels seems to promise the achievement of reduced macrovascular complications—our Holy Grail, but somehow this accomplishment stays just beyond our grasp.
Evidence-Based Medicine—A Brief Review
Elliot J. Rayfield
Evidence-based medicine is a hot topic for primary care physicians, internists, endocrinologists, and the public. But what exactly is it?
Your Clinical Practice—Making Our Diabetes Patients’ Office Visits More Productive
Timothy S. Reid
If we can consider how we might make even one change to improve our health care procedures, we might also be able to help improve not only the capabilities and skills of each member of our health care teams but also the ability of our patients to engage in effective diabetes self-care.
A Report from the 45th Annual Meeting of the European Association for the Study of Diabetes
The annual meeting of the European Association for the Study of Diabetes (EASD) is the most important European forum for the exchange of diabetes information. The 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) attracted an estimated 17,000 participants to the Messe Praten Center located in downtown Vienna. Highlighted in this paper are presentations concerning insulin therapy, other therapeutic advances, and analyses of trends in diabetes care.
Hospital Hypoglycemia: From Observation to Action
Haritha Bellam and Susan S. Braithwaite
Evidence indicates that when treatment of hyperglycemia with insulin is provided for certain hospitalized populations, the attainment of appropriate glycemic targets improves nonglycemic outcomes.
Increased Risk for Type 2 Diabetes Mellitus With HIV-1 Infection
John G. Ryan
The proportion of people with HIV-1 infection who have coexisting type 2 diabetes mellitus (DM) is increasing. The higher incidence of type 2 DM in this patient population is associated with increased survival due to advances in HIV treatment, as well as a complex interaction of diabetes risk factors.
Durable Remission of Diabetes After Bariatric Surgery: What Is the Underlying Pathway?
Jennifer B. Wilson and Walter J. Pories
Full and durable remission of type 2 diabetes mellitus, with major reductions in morbidity and mortality, can be achieved with surgery that reduces contact between food and the foregut.
Responses to the July 2009 Case Study
Ronald Tamler and Derek LeRoith
This was the case of a 45-year-old woman with insulin-requiring, uncontrolled type 2 diabetes mellitus, well-controlled hypothyroidism, and obesity.
Letter to the Editors
Luigi F. Meneghini, MD, MBA
The writer is concerned about methodologic limitations in the 7 studies included in the analysis of cost-effectiveness of insulin detemir done by Mona Shimshi, MD, and Christopher K. Johnson, MD. Drs. Shimshi and Johnson respond.
Corrections
Insulin. 2009;4:169–176.
Insulin. 2009;4:136–143.
Author Index
2009
Subject Index
2009
|
